Escherichia coli producing a cephamycinase (CMY-2) from a patient from the Libyan-Tunisian border region

Clinical Microbiology and Infection

Volumn 4, Issue 3, 1998, Pages 168-170

  Bauernfeind, Adolf ^a   Hohl, Peter ^b   Schneider, Ines ^a   Jungwirth, Renate ^a   Frei, Reno ^b  

^a UNIVERSITY OF MUNICH   (Germany)

^b Research Group Human Genetics   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; BACTERIAL ENZYME; BETA LACTAMASE; CEFTRIAXONE; CEPHAMYCINASE; CIPROFLOXACIN; GENTAMICIN; IMIPENEM; TOBRAMYCIN; UNCLASSIFIED DRUG;

ADULT; ANTIBIOTIC SENSITIVITY; ARTICLE; BLOOD CULTURE; CASE REPORT; ESCHERICHIA COLI; GRAM NEGATIVE INFECTION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LIBYAN ARAB JAMAHIRIYA; MALE; PRIORITY JOURNAL; TRAFFIC ACCIDENT; TUNISIA;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; NEGIBACTERIA;

EID: 0031938812     PISSN: 1198743X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1469-0691.1998.tb00384.x     Document Type: Article

References (5)

1. Philippon A, Labia R, Jacoby G. Extended-spectrum β-lactamases. Antimicrob Agents Chemother 1989; 33: 1131-6.
2. Jacoby GA, Medeiros AA. More extended-spectrum β-lactamases. Antimicrob Agents Chemother 1991; 35: 1697-704.
3. Bauernfeind, A, Stemplinger I, Jungwirth R, Giamarellou H. Characterization of the plasmidic β-lactamase CMY-2, which is responsible for cephamycin resistance. Antimicrob Agents Chemother 1996; 40: 221-4.
4. Bauernfeind, A, Chong Y, Schweighart S. Extended broad spectrum β-lactamase in Klebsiella pneumoniae including resistance to cephamycins. Infection 1989; 17: 316-21.
5. Bauernfeind, A, Wagner S, Jungwirth R, Schneider I, Meyer D. A novel class C β-lactamase (FOX-2) in Escherichia coli conferring resistance to cephamycins. Antimicrob Agents Chemother 1997; 41: 2041-6.